‘We now anticipate receiving the Phase 2 data from the ACTIV-2 team in the summer of 2022, which will be factored into the SNG001 clinical development plan to further build the case that SNG001 may have an important role in combatting COVID-19 and future emerging virus threats.’ Only thing that’s different is the slight change of timeline from first half of the year to summer 2022. Everything else is as expected in a RNS for full year results. We have received all of the other latest info recently. Another wait for A2 data; it’s only been since Oct 21. GLA
SD You are the man - sorry for questioning your abilities. ‘A true legend in his own dinner hour.’ Shame you didn’t predict the RNS on that famous Monday in February. I will try to look deeper, or maybe I’ll make 20 predictions and then when I get a couple correct, claim it was due to my superior techniques. No need to reply SD; I get it. ATB
Aether I am extremely calm. Just responding to the TR1 rubbish. It’s not rocket science. Only reason to be invested short term is for this Wednesday’s financials and for the A2 data, which should be here anytime in the next 1-5 weeks. Once these have been delivered, depending on the strength of them, the plan for investors should be pretty clear. My take is: Strong feedback - either buy more and hold for the next year+ or sell on news and buy back in pre-further trial readout. Mixed feedback - sell and invest elsewhere.
SD My take on it is the buying volume is ridiculously low; there are NO big purchases! Hence, why we went from 43p last Monday back to below 30p by the end of trading on Friday. Maybe your theory is different?
Tommy Thanks for sharing yet some more excellent posts. Unlike many on here, I don’t get excited because RM had a little smile or because he looked like he knows it works - I think we’ve been there before and look what happened. Just because we go on another trial, what will be different this time? SOC hasn’t changed; we will however be targeting a specific group of hospitalised patients that have already shown statistical benefit from SNG001. Time will tell, but until then I remain very cautious. GLA
Manifesto Agreed, although maybe RM is quite comfortable taking his hefty wage and just gearing up for the next round of research, rather than facing the pressures that commercialisation might bring? The RNSs have been downplayed and poorly constructed imo. Is there ever a bullish remark made by him? Always ‘maybe’ or ‘if this happens’ or ‘if we can’. If you get a response from Brooke, you’ve done better than me. I’m in a pretty negative mindset of this company currently; the only problem is I’m stuck for the LT. ATB.
Yes, agreed. No mention of EUA application; just more r read watch from a research company. Unless there is a change of hands we haven’t got the team to bring this to commercialisation imo. When was the last time our CEO communicated with us? Let’s hope we receive positive news on the 25th.
Doc Agreed that the article is a joke. What is also a joke is the lack of comms from the company. They have always been so poor at responding to emails, putting out supporting tweets, providing updates for investors, etc. I would say an email of this nature should be sent to Brooke, but I didn’t receive a reply to my last two attempts. Is it too much to expect a tweet about how the conference is going, anything learnt, any networking news, the mood, etc. if there’s nothing to tweet or mention from such a positive event then …? Very amateur; unfortunately I’m stuck in this for a long time. GLA LTHs.
This is simply to do with the timelines, again. We are now looking at another trial which will take place and complete within the next year, hopefully. MMS will manipulate the stock until the next batch.
RE: RNS may not be Monday - data presents after 4.30pm16 May 2022 06:39
Anthony To make it clear, as this has been said many times. If the company has anything of value to the market, they have to, by law, report it immediately. Failure to do so results in…. So, have they any news? Maybe they are still busy at their computers half hour before the presentation? GL
Doc The point is they have revealed nothing of significance 1 working day before the Conference. Whatever they are delivering on Monday will be known to the team, now. I have previously said, ‘I hope I’m wrong’ but I don’t see how it can be any different? For me, there are only disappointments to come, again.
No RNS as the Conference opens, so clearly nothing of significance has been unearthed that is market sensitive. RM will not resign as he is paid a lot of money, same as Boris the berk. Can LTHs suffer any more at the hands of this company? Of course, there is Monday!